Risk of renal complications and death in young and middle-aged Swedes with parental type 1 diabetes: a nation-wide, prospective cohort study
Fredriksson M, Persson E, Möllsten A, Lind T
BMJ Open Diabetes Res Care. 2025;13(1):e004709.
Leggi
Breaking news
Comparative effectiveness of individual sodium-glucose cotransporter 2 inhibitors
Shin H, Paik JM, Everett BM, et al.
JAMA Intern Med. Pub. online 21 Jan 2025.
Leggi
Active targeting of type 1 diabetes therapies to pancreatic beta cells using nanocarriers
Collins J, Farnsworth NL
Diabetologia. Pub. online 23 Jan 2025.
Abstract
Leggi
Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA1c levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trial
Davies MJ, van der Meer P, Verma S, Patel S, et al.
Lancet Diabetes Endocrinol. Pub. online 20 Jan 2025.
Leggi
Effectiveness of empagliflozin vs dapagliflozin for kidney outcomes in type 2 diabetes
Bonnesen K, Heide-Jørgensen U, Christensen DH
JAMA Intern Med. Pub. online 21 Jan 2025.
Leggi
Association between use of sodium-glucose co-transporter-2 inhibitor and the risk of incident dementia: a population-based cohort study
Abdullah Z, Cui Y, Platt RW, et al.
BMJ Open Diabetes Res Care. 2025;13(1):e004541.
Leggi
Outcome evaluation and cost-effectiveness analysis for an integrated multidisciplinary diabetic limb salvage program: a combined observational and simulation study
Ge L, Sun Y, Tan E, et al.
BMJ Open Diabetes Res Care. 2025;13(1):e004688.
Leggi
Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated HbA1c using the MiniMed 780G system
Zhou Y, Boucsein A, Michaels VR, et al.
Diabetes Obes Metab. Pub. online 20 Jan 2025.
Leggi
Effect of insulin sensitivity, insulin secretion, and beta cell function on the remission of type 2 diabetes: A post hoc analysis of the IDEATE trial
Wu X, Huang Q, Ding Y, et al.
Diabetes Obes Metab. Pub. online 13 Jan 2025.
Leggi
Cardiac metabolic index as a predictor of new-onset diabetes in non-alcoholic fatty liver disease patients: a longitudinal cohort analysis
Hou S, Wang Y, Wei Z, et al.
BMC Endocr Disord. 2025;25(1):13.
Leggi